Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Asset Utilization Ratio (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.03 as the latest value for Q2 2025.

  • On a quarterly basis, Asset Utilization Ratio changed N/A to 0.03 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.03, a N/A change, with the full-year FY2023 number at 0.02, changed N/A from a year prior.
  • Asset Utilization Ratio was 0.03 for Q2 2025 at Centessa Pharmaceuticals, up from 0.03 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.03 in Q2 2025 to a low of 0.03 in Q4 2023.
  • A 4-year average of 0.0 and a median of 0.01 in 2024 define the central range for Asset Utilization Ratio.
  • Biggest YoY gain for Asset Utilization Ratio was 70.46% in 2023; the steepest drop was 70.46% in 2023.
  • Centessa Pharmaceuticals' Asset Utilization Ratio stood at 0.02 in 2022, then plummeted by 70.46% to 0.03 in 2023, then soared by 81.03% to 0.01 in 2024, then soared by 677.13% to 0.03 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Asset Utilization Ratio are 0.03 (Q2 2025), 0.03 (Q1 2025), and 0.01 (Q3 2024).